We selected pancreatic cancer cell lines PANC1 and Patu-8988 with both KRAS and TP53 mutations and KP-4 and PANC-0327 with only KRAS mutations to verify the dependence of pancreatic cancer survival on TP53 (Supplementary Table 5). This evidence concerns the gene KRAS and pancreatic neoplasm.